Literature DB >> 34326935

Ventricular Fibrillation Arrest and Pulmonary Homograft Rupture During Transcatheter Pulmonary Valve: Successful Rescue by Heart Team.

Lamees I El Nihum1, Zhongyu Li2, Mahesh Ramchandani2, Michael J Reardon2, Erik E Suarez2, Thomas E MacGillivray2, Valeria Duarte2, C Huie Lin2.   

Abstract

We describe a 31-year-old woman with pulmonary homograft rupture and ventricular fibrillation arrest complicating a transcatheter pulmonary valve (TPV) procedure. She underwent extracorporeal membrane oxygenation (ECMO) with immediate surgical repair including bioprosthetic pulmonary valve replacement. She had difficulty weaning off ECMO due to hyperacute failure of the valve and ultimately underwent successful hybrid TPV with complete recovery. This case illustrates the importance of the heart team approach during catheter and surgical interventions in adult congenital heart disease. Copyright:
© 2021 The Author(s).

Entities:  

Keywords:  bicuspid aortic valve; congenital heart defect; pulmonic valve; stents; valve repair; valve replacement

Year:  2021        PMID: 34326935      PMCID: PMC8298125          DOI: 10.14797/CAVR7956

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


HISTORY OF PRESENTATION AND PAST MEDICAL HISTORY

A 31-year-old woman was admitted for chest pressure, episodes of presyncope, lower extremity edema, and dyspnea on exertion. She had a history of severe bicuspid aortic stenosis requiring the Ross procedure at age 16, including a 24-mm right-ventricle-to-pulmonary-artery (RV-PA) homograft (Figure 1 A); however, this was complicated by left coronary artery (LCA) endarteritis and pseudoaneurysm, requiring a second surgical repair. The present work-up revealed severe RV-PA homograft stenosis (Figure 1 B, Video 1).
Figure 1

Post-Ross right-ventricle-to-pulmonary-artery (RV-PA) homograft. (A) Ross procedure schematic. Source: Medical gallery of Blausen Medical, WikiJournal of Medicine, Wikiversity. (B) Cardiovascular magnetic resonance imaging demonstrated severe RV-PA homograft stenosis with high velocity jet directed toward the pulmonary artery (PA). LV: left ventricle

Post-Ross right-ventricle-to-pulmonary-artery (RV-PA) homograft. (A) Ross procedure schematic. Source: Medical gallery of Blausen Medical, WikiJournal of Medicine, Wikiversity. (B) Cardiovascular magnetic resonance imaging demonstrated severe RV-PA homograft stenosis with high velocity jet directed toward the pulmonary artery (PA). LV: left ventricle She was taken to the catheterization lab for transcatheter pulmonary valve (TPV) implantation. Serial balloon dilation of the RV-PA homograft was performed (18 mm × 2 cm Vida™, 20 mm, and 22 mm × 4 cm Atlas® Gold balloons, Bard Peripheral Vascular, Inc.) with excellent hemodynamic recovery after balloon deflation. However, on final balloon inflation (24 mm × 4 cm Atlas® Gold), she had no return of arterial pressure, and rhythm degenerated into ventricular fibrillation (VF). RV-PA homograft rupture with free bleeding into mediastinum Acute coronary occlusion due to external compression from fractured RV-PA homograft fragment Acute RV failure due to serial occlusion of RV outflow Distal pulmonary arterial perforation with uncontrolled hemorrhage

INVESTIGATIONS AND MANAGEMENT

Following defibrillation, the patient degenerated back into VF, requiring multiple rounds of defibrillation and cardiopulmonary resuscitation (CPR). During spontaneous circulation, aortic root and pulmonary angiography (Figure 2, Video 2) revealed no free bleeding from the RV-PA homograft, but it did show contrast extravasation from the neoaorta via the LCA into the RV-PA homograft. The patient was cannulated for extracorporeal membrane oxygenation (ECMO) and transferred to the operating room (OR). There she was placed on cardiopulmonary bypass and her heart arrested, at which time pulmonary arteriotomy revealed a longitudinal split posteriorly in the wall of the homograft. Behind this, several pledgets were visible from the prior LCA pseudoaneurysm repair. The LCA itself had been completely disrupted as a result of the homograft split.
Figure 2

Balloon dilation of right-ventricle-to-pulmonary-artery (RV-PA) homograft. (A) Lateral view of left ventricular outflow tract (LVOT) angiogram during 24-mm balloon inflation. The left coronary artery (LCA) was not well seen (yellow arrow). (B) Neoaortic (Ao) root angiogram post-balloon deflation demonstrates contrast extravasation from the left coronary ostium to the pulmonary artery (PA). (C) Frontal view of LVOT angiogram in retrospect demonstrates compression of the neoaorta by the inflated balloon rather than poor contrast filling due to obstructed cardiac output. RCA: right coronary artery; LV: left ventricle

Balloon dilation of right-ventricle-to-pulmonary-artery (RV-PA) homograft. (A) Lateral view of left ventricular outflow tract (LVOT) angiogram during 24-mm balloon inflation. The left coronary artery (LCA) was not well seen (yellow arrow). (B) Neoaortic (Ao) root angiogram post-balloon deflation demonstrates contrast extravasation from the left coronary ostium to the pulmonary artery (PA). (C) Frontal view of LVOT angiogram in retrospect demonstrates compression of the neoaorta by the inflated balloon rather than poor contrast filling due to obstructed cardiac output. RCA: right coronary artery; LV: left ventricle The LCA was ligated and a bypass performed via saphenous vein graft to the left anterior descending artery. The posterior wall of the RV-PA homograft was reconstructed using a bovine pericardial patch, and a 23-mm bovine pericardial valve was implanted (Perimount Magna Ease, Edwards Lifesciences Corp.). A pericardial patch was sewn onto the anterior aspect of the homograft conduit. Initially, the patient could not be weaned from bypass and returned to the intensive care unit on ECMO, and she continued to require ECMO support on postoperative day (POD) 1. She was taken to the hybrid OR on POD 2 for decannulation, but echocardiography revealed severe prosthetic pulmonary valve stenosis with a velocity of 5 m/s (Figure 3). Through a purse-string suture, intraoperative angiogram via direct RV puncture revealed a restricted orifice in the valve’s anterior (Figure 4 A) with a filling defect or fixed leaflet.
Figure 3

Prosthetic pulmonary valve stenosis following surgical replacement. On extracorporeal membrane oxygenation, the newly-placed surgical bioprosthetic pulmonary valve exhibited high velocity (5 m/s) on transesophageal echocardiogram: (A) two-dimensional, (B) color, and (C) continuous-wave Doppler.

Figure 4

Hybrid pulmonary valve replacement. (A) Intraoperative right ventricular outflow tract angiogram demonstrated restrictive orifice and anterior filling defect. (B) A Palmaz P4010XL stent (red arrow) deployed across the prosthetic pulmonary valve (yellow arrows) completely ablated the orifice restriction. (C) Post-valve angiography demonstrated competency of the Melody valve (green arrows). PA: pulmonary artery; RV: right ventricle

Prosthetic pulmonary valve stenosis following surgical replacement. On extracorporeal membrane oxygenation, the newly-placed surgical bioprosthetic pulmonary valve exhibited high velocity (5 m/s) on transesophageal echocardiogram: (A) two-dimensional, (B) color, and (C) continuous-wave Doppler. Hybrid pulmonary valve replacement. (A) Intraoperative right ventricular outflow tract angiogram demonstrated restrictive orifice and anterior filling defect. (B) A Palmaz P4010XL stent (red arrow) deployed across the prosthetic pulmonary valve (yellow arrows) completely ablated the orifice restriction. (C) Post-valve angiography demonstrated competency of the Melody valve (green arrows). PA: pulmonary artery; RV: right ventricle A Palmaz P4010XL stent (Cordis) was deployed on a 22-mm × 4-cm Balloon in Balloon catheter (NuMED) within the bioprosthetic valve, completely expanding the orifice. A 22-mm Melody valve (Medtronic) was implanted with no evidence of regurgitation on final evaluation (Figure 4 B-C, Video 3). The patient was decannulated from ECMO on POD 3 and was extubated and ambulating on POD 4. Postoperative imaging showed normal RV size and function with normal velocity and pressure gradient across the pulmonary valve (Figure 5) and significant improvement of regurgitation (Video 4). She was discharged in excellent condition and was clinically well at 6-month follow-up.
Figure 5

Postoperative echocardiogram. Post-hybrid valve transesophageal echocardiogram demonstrated normal velocity and pressure gradient across the pulmonary valve.

Postoperative echocardiogram. Post-hybrid valve transesophageal echocardiogram demonstrated normal velocity and pressure gradient across the pulmonary valve.

DISCUSSION

RV-PA homograft degeneration can be seen in up to 50% to 55% of patients within 10 years of initial surgical repair and 5 to 6 years after the second.[1] TPV can be an alternative to reduce the open surgeries these patients require but is in the highest risk category of congenital heart interventions.[1,2] Although a key component of TPV, balloon dilation of the RV-PA homograft can cause complications such as conduit tear/rupture and coronary arterial compression.[1] Conduit rupture has been reported during balloon dilation in approximately 9% of cases; although balloon expandable covered stents can be used to mitigate these events, in some cases such as ours, surgical rescue may still be required.[1,3,4] Risk factors include unusual angles in the right ventricular outflow tract (RVOT), use of bicuspidized homografts, heavy calcification, conduit type and size at implant, stenotic diameter, and balloon size.[3,4,5] Coronary arterial compression can complicate up to 5% of RV-PA balloon dilations.[6] Simultaneous aortic root or coronary angiogram with balloon inflation in the RV-PA conduit before stent/TPV deployment allows intraprocedural assessment for coronary compression.[6] Generally, coronary compression during balloon dilation of the RV-PA conduit is relieved after balloon deflation if the stent/TPV is not implanted. Importantly, VF is unusual in RV-PA homograft rupture, and to our knowledge this is the first report of RV-PA homograft rupture into a reimplanted LCA. This catastrophic event raises several questions: (1) Should an aortogram have been performed at smaller-diameter balloon dilation? (2) Could the patient have been managed using transcatheter rescue with covered stents in both the LCA and RV-PA homograft? (3) Could rescue procedures have been better prepared or managed more efficiently? Close multidisciplinary collaboration through rapid defibrillation, CPR, ECMO, and surgical repair was critical to this patient’s survival. Immediate transfer to the OR enabled cardiac protection (cardioplegia) and venting of the left atrium, which was important to the outcome because the patient continued to have myocardial ischemia with the LCA-to-homograft shunt and cardiac demand due to left ventricular load on the ECMO circuit. Likewise, hybrid intervention on the hyperacutely failed bioprosthetic pulmonary valve was another remarkable result of the adult congenital heart disease (ACHD) heart team approach.[7] Also remarkable was the rapid failure of the freshly implanted bioprosthetic valve. Our surgical team hypothesized that reduced RVOT flow while on ECMO likely played a role in its hyperacute failure. Failure of bioprosthetic valves while on ECMO has been reported, with evidence of fusion of the bioprosthetic cusps in valves implanted in the mitral position; this is thought to be related to thrombus formation in the low-flow state.[8,9] Alternatively, cranial malrotation of the pulmonary prosthetic valve has been reported as causing functional valve failure.[10]

CONCLUSIONS

Interventional procedures such as TPV are important advancements in ACHD and can be an alternative to open surgery, but they are not without risk. Close collaboration with a heart team at a specialized ACHD center is required to prepare for and manage complications in these complex cases. Preprocedural magnetic resonance imaging demonstrated severe stenosis and regurgitation of the right-ventricle-to-pulmonary-artery homograft. URI: https://s3-eu-west-1.amazonaws.com/ubiquity-partner-network/up/journal/mdcvj/mdcvj-17-2-35-s1.mp4 Extravasation of contrast from the aortic root suggested aortopulmonary fistula in the setting of homograft rupture into the previously repaired left coronary artery hood. URI: https://s3-eu-west-1.amazonaws.com/ubiquity-partner-network/up/journal/mdcvj/mdcvj-17-2-35-s2.mp4 Postprocedural angiography demonstrated significant improvement of pulmonary regurgitation following Melody valve implantation. URI: https://s3-eu-west-1.amazonaws.com/ubiquity-partner-network/up/journal/mdcvj/mdcvj-17-2-35-s3.mp4 Postprocedural magnetic resonance imaging demonstrated significant improvement of pulmonary regurgitation following Melody valve implantation. URI: https://s3-eu-west-1.amazonaws.com/ubiquity-partner-network/up/journal/mdcvj/mdcvj-17-2-35-s4.mp4
  10 in total

1.  Hybrid Approach to Pulmonary Valve Replacement with Melody Prosthesis Following Pulmonary Banding.

Authors:  Walid K Abu Saleh; Chun H Lin; John P Breinholt; Basel Ramlawi
Journal:  J Card Surg       Date:  2016-01-19       Impact factor: 1.620

2.  Prosthetic Pulmonary Valve Stenosis: A Different Way to Solve the Problem.

Authors:  Thomas Schroeter; Philipp Lurz; Philipp Kiefer; Mahmoud Wehbe; Ingo Dähnert
Journal:  Ann Thorac Surg       Date:  2015-09       Impact factor: 4.330

3.  Predictors and outcomes of right ventricular outflow tract conduit rupture during percutaneous pulmonary valve implantation: a multicentre study.

Authors:  Younes Boudjemline; Sophie Malekzadeh-Milani; Mehul Patel; Jean-Benoit Thambo; Damien Bonnet; Laurence Iserin; Alain Fraisse
Journal:  EuroIntervention       Date:  2016-01-22       Impact factor: 6.534

Review 4.  Transcatheter Pulmonary Valve Replacement: Current State of Art.

Authors:  Wail Alkashkari; Amani Alsubei; Ziyad M Hijazi
Journal:  Curr Cardiol Rep       Date:  2018-03-15       Impact factor: 2.931

5.  Covered CP Stent for Treatment of Right Ventricular Conduit Injury During Melody Transcatheter Pulmonary Valve Replacement.

Authors:  Jeffrey W Delaney; Bryan H Goldstein; Ram N Bishnoi; Karl S M Bisselou; Kerry McEnaney; Matthew Minahan; Richard E Ringel
Journal:  Circ Cardiovasc Interv       Date:  2018-10       Impact factor: 6.546

6.  Early bioprosthetic mitral valve failure due to fusion of the cusps.

Authors:  Natalie Glaser; Jan Liska; Jan Hultman; Peter Svenarud
Journal:  Ann Thorac Surg       Date:  2013-08       Impact factor: 4.330

7.  Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience.

Authors:  Brian H Morray; Doff B McElhinney; John P Cheatham; Evan M Zahn; Darren P Berman; Patrick M Sullivan; James E Lock; Thomas K Jones
Journal:  Circ Cardiovasc Interv       Date:  2013-09-24       Impact factor: 6.546

8.  Rescue surgery following percutaneous pulmonary valve implantation.

Authors:  Martin Kostolny; Victor Tsang; Johannes Nordmeyer; Carin Van Doorn; Alessandra Frigiola; Sachin Khambadkone; Marc R de Leval; Philipp Bonhoeffer
Journal:  Eur J Cardiothorac Surg       Date:  2008-02-05       Impact factor: 4.191

9.  Incidence and management of life-threatening adverse events during cardiac catheterization for congenital heart disease.

Authors:  C Huie Lin; Sanjeet Hegde; Audrey C Marshall; Diego Porras; Kimberlee Gauvreau; David T Balzer; Robert H Beekman; Alejandro Torres; Julie A Vincent; John W Moore; Ralf Holzer; Laurie Armsby; Lisa Bergersen
Journal:  Pediatr Cardiol       Date:  2013-07-31       Impact factor: 1.655

10.  Mitral valve bio-prosthesis and annuloplasty thrombosis during extracorporeal membrane oxygenation: case series.

Authors:  Abhinay Challa; Jilani Latona; John Fraser; Michelle Spanevello; Gregory Scalia; Darryl Burstow; David Platts
Journal:  Eur Heart J Case Rep       Date:  2020-04-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.